Lombard Odier Asset Management (USA)’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-30,000	Closed	-$1.01M	–	193
2017 Q2	$1.01M	Hold	30,000	–	–	0.08%	126
2017 Q1	$888K	Buy	+30,000	New	+$888K	0.08%	130